retinopathy glp 1 PDF] GLP-1R as a Target for the Treatment of Diabetic Retinopathy: Friend or Foe? Frontiers | Unlocking the potential

Intestinal luminal nitrogen metabolism: role of the gut microbiota and consequences for the host

To understand why this peptide does not affect hunger, cortisol, or eating behavior, it is essential to examine where and how it acts within the bodys metabolic pathways

It also has many drivers, so one gut fix rarely works for everyone

Nissl, F

A TD Cowen analyst said to Reuters that the current status quo lets compounders create copycat drugs if they make minor tweaks they claim benefit specific patient groups, leaving the door pretty wide open. All of this lands as Novo already faces pricing and patent pressure

This is a secondary mechanism, but clinically relevant